IBD is incurable and Australia
has one of the highest prevalence rates with one in 250 Australians diagnosed. There is a critical need for improved
therapeutics that will extend periods of disease-free remission and improve quality of life for IBD patients.
Biotech companies such as Microba
are working on research programs to develop diagnostics and therapeutics from
the gut microbiome (gut bacteria). Using big data approaches, they have identified
20 bacterial species found in healthy individuals but rarely detected in
Crohn’s Disease and/or Ulcerative Colitis.
19 May is World IBD Day and May is IBD Awareness